65,437 trials
Lung Cancer · Sexual Dysfunction
Primary: Number of Participants With Different Type, Frequency and Severity of Sexual Dysfunction — 71; 275; 76; 51 Participants
Cardioembolic Stroke · Atrial Fibrillation
Primary: Number of Participants With Successful Stand-Alone Left Atrial Appendage Closure Using SentreHeart Lariat Device as Measured by Left Atrial Appendage Closure Rates — 6…
Non-Small Cell Lung Cancer
Primary: Rate of Dose Limiting Toxicity — 0 participants
Acute Ischemic Stroke
Primary: Number of Adverse Events — 3; 0; 2; 2 event
Hyperglycemia
Primary: Percentage of Time in Target Glycemic Ranges — 76; 65; 69; 61 percentage of time in target ranges — p=<0.001
Diabetes Mellitus, Type 1
Primary: Number of Participants With One or More Severe Hypoglycemia Events — 0; 0 Participants
Survivorship · Cancer · Symptoms and Signs
Primary: Number of Participants Who Logged Data at Least Three Times in the POSTHOC App — 12; 1 Participants
E-cigarette Use
Primary: Number of Students Who Currently Use E-cigarettes — 9; 4 Participants
Colorectal Cancer · Cholangiocarcinoma
Primary: Number of Patients Requiring Stent Replacements — 1; 2; 1; 14 Participants
Fatigue · Ovarian Cancer
Primary: Change in Level of Fatigue at Week 6 — 5.57; 5.30; 5.38; 3.52 mean score
Haemorrhoidal Disease
Primary: Assessment of Performance by the Improvement in the Quality of Life Measured Through the Score on The Short Health Scale for Haemorrhoidal Disease (SHSHD) — 14.04; 7.80…
Microbicide Delivery System Perceptibility and Acceptability
Primary: User Sensory Perception & Experience (USPE; Perceptibility) Scale Item Means — 3.67; 3.29; 3.86; 3.42 units on a scale
Neonatal Sepsis · Preterm Infants
Primary: Change From Baseline in the Modified Töllner Sepsis Scoring System After 7 Days — 7; 7; 8; 9 Score — p=<0.001
Ventricular Tachycardia · Ischemic Cardiomyopathy
Primary: Number of Participants With Ventricular Tachycardia Inducibility — 6 Participants
Gambling Addiction · Gambling Disorder · Gambling Disorder Treatment
Primary: Change in Self-Stigmatization Score as Measured by the Self-Stigma Scale (SSS). Baseline (Week 0) to Post-treatment (Week 4) and Follow-up (Week 8) — 82.77; 110.3…